RSPO4 and thyroid gland carcinoma: Metastatic and non-metastatic thyroid cancer cell lines carrying CRISPR-RSPO4 knockout, and their controls were used to understand how the gene modulation could influence the phenotypic changes related to cell movement and invasion.